Health and Fitness Health and Fitness
Wed, December 1, 2010
[ Wed, Dec 01st 2010 ] - Market Wire
Apricus Biosciences Appoints Manufacturer for Vit .. oved Drug to Treat Erectile Dysfunction in Canada
[ Wed, Dec 01st 2010 ] - Market Wire
CIGNA Announces Tender Offer for any and all of its 8.50% Senior Notes due 2019
[ Wed, Dec 01st 2010 ] - Market Wire
Bristol-Myers Squibb and Alvin Ailey American Dan .. -Its-Kind Collaboration to Express the Stories of
[ Wed, Dec 01st 2010 ] - Market Wire
Oncolytics Biotech® Inc. Announces Start of .. lment in Randomized Phase II Ovarian Cancer Study
[ Wed, Dec 01st 2010 ] - Market Wire
Medisafe 1 Technologies Locking Syringe Adds ERP Compatibility Feature
[ Wed, Dec 01st 2010 ] - Market Wire
Aetna Names Michael Mathias Chief Information Officer
[ Wed, Dec 01st 2010 ] - Market Wire
CytRx Initiating Phase 2b Clinical Trial with Tamibarotene in Advanced Lung Cancer
[ Wed, Dec 01st 2010 ] - Market Wire
Genzyme Completes Sale of Genetic Testing Business to LabCorp
[ Wed, Dec 01st 2010 ] - Market Wire
LabCorp Successfully Completes Acquisition of Genzyme Genetics
[ Wed, Dec 01st 2010 ] - Market Wire
Synovis Life Technologies Reports 21 Percent Year .. ear Revenue Growth for Fiscal 2010 Fourth Quarter
[ Wed, Dec 01st 2010 ] - Market Wire
Allos Therapeutics Announces FOLOTYN® Data to Be .. t the 2010 Chicago Multidisciplinary Symposium in
[ Wed, Dec 01st 2010 ] - Market Wire
MEDNAX Announces the Acquisition of Washington State Pediatric Critical Care Practice
[ Wed, Dec 01st 2010 ] - Market Wire
BioScrip Appoints David W. Froesel, Jr. as Execut .. President, Chief Financial Officer and Treasurer
[ Wed, Dec 01st 2010 ] - Market Wire
OSI Pharmaceuticals, Inc. Exercises Option under .. nd Translational Research Collaboration with AVEO
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
Teva Announces $1 Billion Share Repurchase Program
[ Tue, Nov 30th 2010 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 5th Cardiovascular, Diabetes & Obesity Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Gilead Sciences to Present at the NASDAQ OMX 25th Investor Program
[ Tue, Nov 30th 2010 ] - Market Wire
HealthSpring, Inc. Completes Acquisition of Bravo Health, Inc.
[ Tue, Nov 30th 2010 ] - Market Wire
InSite Vision Names Timothy Ruane Chief Executive Officer
[ Tue, Nov 30th 2010 ] - Market Wire
Micromet to Present at the 2010 Piper Jaffray Healthcare Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Spectranetics to Present at the 5th Annual Canacc .. ular, Diabetes & Obesity Conference on December 7
[ Tue, Nov 30th 2010 ] - Market Wire
Ruim 260 presentaties en posters over producten v .. tijdens 52ste jaarvergadering van American Societ
[ Tue, Nov 30th 2010 ] - Market Wire
Merck KGaA, Teva Pharmaceuticals Industries, Biogen Idec, Elan and POSCO
[ Tue, Nov 30th 2010 ] - Market Wire
NewGene Ltd. Achieves Certification to Provide NimbleGen Sequence Capture Services in UK
[ Tue, Nov 30th 2010 ] - Market Wire
Seattle Genetics Announces Additions to Commercial Leadership Team
[ Tue, Nov 30th 2010 ] - Market Wire
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
[ Tue, Nov 30th 2010 ] - Market Wire
AOAC Certifies SDIX Salmonella 24-hour Test System for Food Processing Environmental Testing
[ Tue, Nov 30th 2010 ] - Market Wire
Array BioPharma Achieves Clinical Milestone in Celgene Collaboration
[ Tue, Nov 30th 2010 ] - Market Wire
Viral Genetics Announces Initiation of Research Coverage by Research 2.0
[ Tue, Nov 30th 2010 ] - Market Wire
Ms de 260 presentaciones y sesiones que evalan lo .. estacadas durante la 52 edicin de la reunin anual

Ms de 260 presentaciones y sesiones que evalan los productos de Celgene sern destacadas durante la 52 edicin de la reunin anual


Published on 2010-11-30 05:26:05 - Market Wire
  Print publication without navigation


BOUDRY, Suiza--([ BUSINESS WIRE ])--Celgene International Srl (NASDAQ: CELG) ha comunicado que investigadores clnicos de los centros de investigacin del cncer ms destacados presentarn datos sobre los ensayos clnicos ms recientes y en curso en ms de 260 sesiones y presentaciones, incluidas ms de 65 presentaciones orales que evalan los productos de Celgene sobre el tratamiento de la leucemia durante la 52 edicin de reunin anual de la American Society of Hematology en Orlando, Florida, del 4 al 7 de diciembre.

Ms informacin en [ www.hematology.org ].

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources